Hims&Hers stock falls after Lilly rules out partnership

Go back to Hims&Hers stock falls after Lilly rules out partnership

Citi on Hims and Hers (HIMS): 'If HIMS does end up partnering with LLY, in our view it would signal that HIMS is “throwing in the towel” on compounded GLP-1s'

June 10, 2025 3:25 PM EDT

Citi analyst Daniel Grosslight reiterated a Sell rating and $30.00 price target on Hims and Hers (NYSE: HIMS).

The analyst comments "At an investor conference this morning, LLYs CFO noted that when LLY partners with virtual health companies, they require those companies to stop offering... More